Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older

NCT01165177 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

16165

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Zoster

Interventions

BIOLOGICAL: Herpes Zoster Vaccine GSK1437173A
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline